Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 22, 2025
A Risk-Based, Qtpp-Driven Framework For Semi-Solid Extrusion 3d Printing of Personalized Medicines: Integrating Hospital Compounding and Clinical Trial RegulationMaxime Annereau, Philippe-Henri Secretan, Bernard Do
Pharmaceutics|September 27, 2025
A Risk-Based Framework for Hospital Compounding: Integrating Degradation Mechanisms and Predictive ToxicologyPhilippe-Henri Secretan, Maxime Annereau, Bernard Do
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 16, 2025
Hybrid GPP-hospital control strategy for semi-solid extrusion 3D printing of ONC201 chewable units in pediatric oncologyStephanie Ramos, Marina Vignes, Philippe-Henri Secretan, et al.
Pharmaceutical Development and Technology|September 17, 2024
Preformulation evaluation of selumetinib for topical application: skin distribution and photodegradation analysis using MALDI imaging and LC-MS/MSEdith Nicol, Bernard Do, Marina Vignes, et al.
Pharmaceutics|June 27, 2025
Stability-Guided Formulation of a Light-Sensitive D-LSD Capsule for Clinical InvestigationBernard Do, Luc Mallet, Maxime Annereau, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
3D-Printed, Liquid-Filled Capsules of Concentrated and Stabilized Polyphenol Epigallocatechin Gallate, Developed in a Clinical TrialPhilippe-Henri Secretan, Victoire Vieillard, Olivier Thirion, et al.
Pharmaceutics|October 28, 2023
Molecular Mechanisms Involved in the Chemical Instability of ONC201 and Methods to Counter Its Degradation in SolutionMaxime Annereau, Marina Vignes, Lucas Denis, et al.
International Journal of Pharmaceutics|November 27, 2024
Development of a pediatric oral solution of ONC201 using nicotinamide to enhance solubility and stabilityMaxime Annereau, Philippe-Henri Secretan, Marina Vignes, et al.
Pharmaceutics|December 23, 2022
Identification of the Major Degradation Pathways of SelumetinibTahar Sif Eddine Bouchema, Maxime Annereau, Victoire Vieillard, et al.
Pageof 8